Expression of circulating miRNA-21 and miR-99b in HBV-related liver cirrhosis and hepatocellular carcinoma

Our primary objective was to assess whether these miRNAs could serve as potential biomarkers for distinguishing hepatocellular carcinoma (HCC), even in its early stages, from other liver diseases, particularly liver cirrhosis (LC).